Asher MI, Montefort S, Bjorksten B et al (2006) Worldwide time trends in the prevalence and symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 368:733–743. doi:10.1016/S0140-6736(06)69283-0
Bradding P, Walls AF, Holgate ST (2006) The role of mast cells in the pathophysiology of asthma. J Allergy Clin Immunol 117:1277–1284. doi:10.1016/j.jaci.2006.02.039
Gibson PG, Allen CJ, Yang JP et al (1993) Intraepithelial mast cells in allergic and nonallergic asthma: assessment using bronchial brushings. Am Rev Respir Dis 148:80–86
Mekori YA, Oh CK, Metcalfe DD (1993) IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3: prevention of apoptosis by c-kit ligand. J Immunol 151:3775–3784
Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ (1994) The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144:321–328
Yanagida M, Fukamachi H, Ohgami K et al (1995) Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86:3705–3714
Shelburne CP, Ryan JJ (2001) The role of Th2 cytokines in mast cell homeostasis. Immunol Rev 179:82–93. doi:10.1034/j.1600-065X.2001.790109.x
Kitamura Y, Go S, Hatanaka K (1978) Decrease of mast cells in W/Wv mice and their increase by bone-marrow transplantation. Blood 52:447–452
Kitumara Y, Go S (1979) Decreased production of mast cells in S1/S1d anemic mice. Blood 53:492–497
Heinrich MC, Dooley DC, Freed AC et al (1993) Constitutive expression of steel factor gene by human stromal cells. Blood 82:771–783
Zhang S, Anderson DF, Bradding P et al (1998) Human mast cells express stem cell factor. J Pathol 186:59–66. doi:10.1002/(SICI)1096-9896(199809)186:1<59::AID-PATH140>3.0.CO;2-J
Wershil BK, Tsai M, Geissler EN, Zsebo KM, Galli SJ (1992) The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo: evidence that signaling through the c-kit receptor can induce expression of cellular function. J Exp Med 175:245–255. doi:10.1084/jem.175.1.245
Reber L, Da Silva CA, Frossard N (2006) Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur J Pharmacol 533:327–340. doi:10.1016/j.ejphar.2005.12.067
Möller C, Alfredsson J, Engström M et al (2005) Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim. Blood 106:1330–1336. doi:10.1182/blood-2004-12-4792
Asai K, Kitaura J, Kawakami Y et al (2001) Regulation of mast cell survival by IgE. Immunity 14:791–800. doi:10.1016/S1074-7613(01)00157-1
Alfredsson J, Puthalakath H, Martin H, Strasser A, Nilsson G (2005) Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-xL upon IgE-receptor activation. Cell Death Differ 12:136–144. doi:10.1038/sj.cdd.4401537
Kalesnikoff J, Huber M, Lam V et al (2001) Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14:801–811. doi:10.1016/S1074-7613(01)00159-5
Kitaura J, Song J, Tsai M et al (2003) Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci USA 100:12911–12916. doi:10.1073/pnas.1735525100
Hartmann K, Wagelie-Steffen AL, von Stebut E, Metcalfe DD (1997) Fas (CD95, APO-1) antigen expression and function in murine mast cells. J Immunol 159:4006–4014
Berent-Maoz B, Piliponsky AM, Daigle I, Simon HU, Levi-Schaffer F (2006) Human mast cells undergo TRAIL-induced apoptosis. J Immunol 176:2272–2278
Berent-Maoz B, Salemi S, Mankuta D, Simon HU, Levi-Schaffer F (2008) TRAIL mediated signaling in human mast cells: the influence of IgE-dependent activation. Allergy 63:333–340. doi:10.1111/j.1398-9995.2007.01598.x
Ekoff M, Kaufmann T, Engström M et al (2007) The BH3-only protein Puma plays an essential role in cytokine deprivation induced apoptosis of mast cells. Blood 110:3209–3217. doi:10.1182/blood-2007-02-073957
Simon D, Simon HU (2007) Eosinophilic disorders. J Allergy Clin Immunol 119:1291–1300. doi:10.1016/j.jaci.2007.02.010
Rothenberg ME, Hogan SP (2006) The eosinophil. Annu Rev Immunol 24:147–174. doi:10.1146/annurev.immunol.24.021605.090720
Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79:3101–3109
Owen WF, Rothenberg ME, Petersen J et al (1989) Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 170:343–348. doi:10.1084/jem.170.1.343
Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K (1997) Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 158:3902–3908
Tumes DJ, Cormie J, Calvert MG et al (2007) Strain-dependent resistance to allergen-induced lung pathophysiology in mice correlates with rate of apoptosis of lung-derived eosinophils. J Leukoc Biol 81:1362–1373. doi:10.1189/jlb.0106046
Xu J, Jiang F, Nayeri F, Zetterström O (2007) Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin. Respir Med 101:1447–1454. doi:10.1016/j.rmed.2007.01.026
Farahi N, Cowburn AS, Upton PD et al (2007) Eotaxin-1/CC chemokine ligand 11: A novel eosinophil survival factor secreted by human pulmonary artery endothelial cells. J Immunol 179:1264–1273
Conus S, Bruno A, Simon HU (2005) Leptin is an eosinophil survival factor. J Allergy Clin Immunol 116:1228–1234. doi:10.1016/j.jaci.2005.09.003
Bureau F, Seumois G, Jaspar F et al (2002) CD40 engagement enhances eosinophil survival through induction of cellular inhibitor of apoptosis protein 2 expression: possible involvement in allergic inflammation. J Allergy Clin Immunol 110:443–449. doi:10.1067/mai.2002.126781
Dibbert B, Daigle I, Braun D et al (1998) Role for Bcl-xL in delayed eosinophil apoptosis by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood 92:778–783
Segal M, Niazi S, Simons MP, Galati SA, Zangrilli JG (2007) Bid activation during induction of extrinsic and intrinsic apoptosis in eosinophils. Immunol Cell Biol 85:518–524. doi:10.1038/sj.icb.7100075
Dewson G, Cohen GM, Wardlaw AJ (2001) Interleukin-5 inhibits translocation of Bax to mitochondria, cytochrome c release, and activation of caspases in human eosinophils. Blood 98:2239–2247. doi:10.1182/blood.V98.7.2239
Vassina EM, Yousefi S, Simon D, Zwicky C, Conus S, Simon HU (2006) cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis. Eur J Immunol 36:1975–1984. doi:10.1002/eji.200635943
Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R (1995) The signal transduction mechanism of IL-5 in eosinophils: the involvement of lyn tyrosine kinase and the ras-raf 1-MEK-MAP kinase pathway. J Exp Med 181:1827–1834. doi:10.1084/jem.181.5.1827
Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU (1996) Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 183:1407–1414. doi:10.1084/jem.183.4.1407
Pinho V, Souza DG, Barsante MM et al (2005) Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J Leukoc Biol 77:800–810. doi:10.1189/jlb.0704386
van der Bruggen T, Caldenhoven E, Kanters D et al (1995) Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and STAT1α. Blood 85:1442–1448
Simon HU, Yousefi S, Dibbert B, Levi-Schaffer F, Blaser K (1997) Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils. Eur J Immunol 27:3536–3539. doi:10.1002/eji.1830271256
Fujihara S, Jaffray E, Farrow SN, Rossi AG, Haslett C, Hay RT (2005) Inhibition of NF-kappa B by a cell permeable form of I kappa B alpha induces apoptosis in eosinophils. Biochem Biophys Res Commun 326:632–637. doi:10.1016/j.bbrc.2004.11.090
Hasala H, Zhang X, Saarelainen S, Moilanen E, Kankaanranta H (2007) c-Jun N-terminal kinase mediates constitutive human eosinophil apoptosis. Pulm Pharmacol Ther 20:580–587. doi:10.1016/j.pupt.2006.06.004
Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS (1995) Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437–1443
Hebestreit H, Dibbert B, Balatti I et al (1998) Disruption of Fas receptor signaling by nitric oxide in eosinophils. J Exp Med 187:415–425. doi:10.1084/jem.187.3.415
Daigle I, Simon HU (2001) Alternative functions for TRAIL receptors in eosinophils and neutrophils. Swiss Med Wkly 131:231–237
Temkin V, Levi-Schaffer F (2001) Mechanisms of tumour necrosis factor alpha mediated eosinophil survival. Cytokine 15:20–26. doi:10.1006/cyto.2001.0890
Mahajan L, Madan T, Kamal N et al (2008) Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages. Int Immunol 20:993–1007. doi:10.1093/intimm/dxn058
Nutku E, Aizawa H, Hudson SA, Bochner BS (2003) Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101:5014–5020. doi:10.1182/blood-2002-10-3058
Nutku-Bilir E, Hudson SA, Bochner BS (2008) Interleukin-5 priming of human eosinophils alters Siglec-8 mediated apoptosis pathways. Am J Respir Cell Mol Biol 38:121–124. doi:10.1165/rcmb.2007-0154OC
von Gunten S, Simon HU (2007) Autophagic-like cell death in neutrophils induced by autoantibodies. Autophagy 3:67–68
Bochner BS, Alvarez RA, Mehta P et al (2005) Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem 280:4307–4312. doi:10.1074/jbc.M412378200
von Gunten S, Vogel M, Schaub A et al (2007) Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies. J Allergy Clin Immunol 119:1005–1011. doi:10.1016/j.jaci.2007.01.023
Zimmermann N, McBride ML, Yamada Y et al (2008) Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy 63:1156–1163. doi:10.1111/j.1398-9995.2008.01709.x
Meagher LC, Cousin JM, Seckl JR, Haslett C (1996) Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156:4422–4428
Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ (1996) Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 154:237–243
Yasui K, Hu B, Nakazawa T, Agematsu K, Komiyama A (1997) Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 100:1677–1684. doi:10.1172/JCI119692
Hallsworth MP, Giembycz MA, Barnes PJ, Lee TH (1996) Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF. Br J Pharmacol 117:79–86
Shaw DE, Berry MA, Hargadon B et al (2007) Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest 132:1871–1875. doi:10.1378/chest.07-1047
Daigle I, Yousefi S, Colonna M, Green DR, Simon HU (2002) Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signalling in neutrophils. Nat Med 8:61–67. doi:10.1038/nm0102-61
Perianayagam MC, Balakrishnan VS, King AJ, Pereira BJ, Jaber BL (2002) C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int 61:456–463. doi:10.1046/j.1523-1755.2002.00139.x
von Gunten S, Yousefi S, Seitz M et al (2005) Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 106:1423–1431. doi:10.1182/blood-2004-10-4112
Kostylina G, Simon D, Fey MF, Yousefi S, Simon HU (2008) Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A). Cell Death Differ 15:134–142. doi:10.1038/sj.cdd.4402238
Fuchs TA, Abed U, Goosmann C et al (2007) Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176:231–241. doi:10.1083/jcb.200606027
Yousefi S, Gold JA, Andina N et al (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 14:949–953. doi:10.1038/nm.1855
Walmsley SR, Print C, Farahi N et al (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-κB activity. J Exp Med 201:105–115. doi:10.1084/jem.20040624
Yousefi S, Green DR, Blaser K, Simon HU (1994) Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci USA 91:10868–10872. doi:10.1073/pnas.91.23.10868
Daigle I, Simon HU (2001) Critical role for caspases 3 and 8 in neutrophil but not eosinophil apoptosis. Int Arch Allergy Immunol 126:147–156. doi:10.1159/000049506
Altznauer F, Martinelli S, Yousefi S et al (2004) Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med 199:1343–1354. doi:10.1084/jem.20032033
Villunger A, Scott C, Bouillet P, Strasser A (2003) Essential role for the BH3-only protein Bim, but redundant roles for Bax, Bcl-2 and Bcl-w in the control of granulocyte survival. Blood 101:2393–2400. doi:10.1182/blood-2002-07-2132
Zheng X, Karsan A, Duronio V et al (2002) Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5 inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-κB-dependent and -independent pathways. Immunol 107:306–315. doi:10.1046/j.1365-2567.2002.01517.x
Matsumoto K, Maeda A, Bochner BS, Wakiguchi H, Saito H (2008) Induction of apoptosis in human basophils by anti-Fas antibody treatment in vitro. Int Arch Allergy Immunol 146(suppl. 1):40–46. doi:10.1159/000126060
Didichenko SA, Spiegl N, Brunner T, Dahinden CA (2008) IL-3 induces a Pim1-dependent anti-apoptotic pathway in primary human basophils. Blood. doi:10.1182/blood-2008-04-149419
Umetsu DT, DeKruyff RH (2006) The regulation of allergy and asthma. Immunol Rev 212:238–255. doi:10.1111/j.0105-2896.2006.00413.x
Akdis CA, Blaser K, Akdis M (2004) Apoptosis in tissue inflammation and allergic disease. Curr Opin Immunol 16:717–723. doi:10.1016/j.coi.2004.09.004
Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229–240. doi:10.1016/0092-8674(93)80065-M
Vella AT, Dow S, Potter TA, Kappler J, Marrack P (1998) Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 95:3810–3815. doi:10.1073/pnas.95.7.3810
Li XC, Demirci G, Ferrari-Lacraz S et al (2001) IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med 7:114–118. doi:10.1038/83253
Kirberg J, Berns A, von Boehmer H (1997) Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 186:1269–1275. doi:10.1084/jem.186.8.1269
Duke RC, Cohen JJ (1986) IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 5:289–299
Hildeman DA, Zhu Y, Mitchell TC et al (2002) Activated T cell death in vivo mediated by pro-apoptotic Bcl-2 family member Bim. Immunity 16:759–767. doi:10.1016/S1074-7613(02)00322-9
Arnold R, Brenner D, Becker M, Frey CR, Krammer PH (2006) How T lymphocytes switch between life and death. Eur J Immunol 36:1654–1658. doi:10.1002/eji.200636197
Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK (1998) Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615–623. doi:10.1016/S1074-7613(00)80566-X
Zhang XR, Zhang LY, Devadas S, Li L, Keegan AD, Shi YF (2003) Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ 10:203–210. doi:10.1038/sj.cdd.4401138
Akdis M, Trautmann A, Klunker S et al (2003) T helper (Th) 2 predominance in atopic disease is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J 17:1026–1035. doi:10.1096/fj.02-1070com
Akkoc T, de Koning PJ, Rückert B, Barlan I, Akdis M, Akdis CA (2008) Increased activation-induced cell death of high IFN-γ-producing Th1 cells as a mechanism of Th2 predominance in atopic diseases. J Allergy Clin Immunol 121:652–658. doi:10.1016/j.jaci.2007.12.1171
Rieux-Laucat F, Le Deist F, Hivroz C et al (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347–1349. doi:10.1126/science.7539157
Fisher GH, Rosenberg FJ, Straus SE et al (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935–946. doi:10.1016/0092-8674(95)90013-6
Devadas S, Das J, Liu C et al (2006) Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 25:237–247. doi:10.1016/j.immuni.2006.06.011
Strasser A, Harris AW, Cory S (1991) Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889–899. doi:10.1016/0092-8674(91)90362-3
Hoetzenecker W, Ecker R, Kopp T, Stuetz A, Stingl G, Elbe-Bürger A (2005) Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. J Allergy Clin Immunol 115:1276–1283. doi:10.1016/j.jaci.2005.02.011
Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ (2007) CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 8:1353–1362. doi:10.1038/ni1536
Maldonado-Lopez R, Maliszewski C, Urbain J, Moser M (2001) Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(−) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 167:4345–4350
Harris NL, Ronchese F (1999) The role of B7 costimulation in T-cell immunity. Immunol Cell Biol 77:304–311. doi:10.1046/j.1440-1711.1999.00835.x
Vieira PL, de Jong EC, Wierenga EA, Kapsenberg ML, Kalinski P (2000) Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instructions. J Immunol 164:4507–4512
van Rijt LS, Jung S, Kleinjan A et al (2005) In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 201:981–991. doi:10.1084/jem.20042311
Kleinjan A, Willart M, van Rijt LS et al (2006) An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol 118:1117–1125. doi:10.1016/j.jaci.2006.05.030
Ingulli E, Mondino A, Khoruts A, Jenkins MK (1997) In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J Exp Med 185:2133–2141. doi:10.1084/jem.185.12.2133
Park Y, Lee SW, Sung YC (2002) Cutting edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3′-OH kinase pathway. J Immunol 168:5–8
Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P (1998) Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 188:2175–2180. doi:10.1084/jem.188.11.2175
Wong BR, Josien R, Lee SY et al (1997) TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075–2080. doi:10.1084/jem.186.12.2075
Hou WS, van Parijs L (2004) A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol 5:583–589. doi:10.1038/ni1071
Arques JL, Regoli M, Bertelli E, Nicoletti C (2008) Persistence of apoptosis-resistant T cell-activating dendritic cell promotes T helper type-2 response and IgE antibody production. Mol Immunol 45:2177–2186. doi:10.1016/j.molimm.2007.12.004
Schuller E, Oppel T, Bornhövd E, Wetzel S, Wollenberg A (2004) Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but not Langerhans cell apoptosis in patients with atopic dermatitis. J Allergy Clin Immunol 114:137–143. doi:10.1016/j.jaci.2004.03.021
Trautmann A, Schmid-Grendelmeier P, Krüger K et al (2002) T cells and eosinophils cooperate in the induction of bronchial epithelial apoptosis in asthma. J Allergy Clin Immunol 109:329–337. doi:10.1067/mai.2002.121460
Trautmann A, Akdis M, Kleeman D et al (2000) T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenic role in eczematous dermatitis. J Clin Invest 106:25–35. doi:10.1172/JCI9199